Robert N. Shapiro’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$1.63M Buy
19,576
+47
+0.2% +$3.9K 0.32% 97
2014
Q3
$1.65M Sell
19,529
-2,957
-13% -$239K 0.31% 100
2014
Q2
$1.82M Sell
22,486
-3,203
-12% -$252K 0.35% 90
2014
Q1
$1.96M Sell
25,689
-21,366
-45% -$1.56M 0.36% 84
2013
Q4
$3.39M Sell
47,055
-11,756
-20% -$817K 0.61% 44
2013
Q3
$4.04M Buy
58,811
+8,296
+16% +$549K 0.71% 36
2013
Q2
$3.2M Buy
+50,515
New +$3.29M 0.67% 38

Other funds holding NVS

Robert N. Shapiro's NVS Position: Q4 2014 in Review

Robert N. Shapiro increased its Novartis (NVS) stake by 0.24% in Q4 2014, buying an estimated $3.9K and bringing the position to 19,576 shares worth $1.63M. The position accounts for 0.32% of the portfolio, ranked #97.

Robert N. Shapiro first reported a position in NVS in Q2 2013 and has held it in 7 quarters since. The position peaked at $4.04M in Q3 2013. 918 funds tracked by Wall St. Rank hold NVS as of Q4 2014.

  • Robert N. Shapiro held 19,576 shares of Novartis worth $1.63M as of Q4 2014.
  • Robert N. Shapiro bought 47 Novartis shares in Q4 2014, an estimated $3.9K.
  • Novartis made up 0.32% of Robert N. Shapiro's portfolio in Q4 2014, its #97 holding.
  • Robert N. Shapiro first reported a position in Novartis in Q2 2013 and has held it in 7 quarters since.
  • Robert N. Shapiro's Novartis position peaked at $4.04M in Q3 2013.
  • 918 funds tracked by Wall St. Rank held Novartis as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.